Rapport Therapeutics director James Healy reports $20.36 million common share acquisition
RAPP•Director James Healy reported indirect purchases of 969,480 Rapport Therapeutics common shares at $21 each, bringing his reported indirect holdings to 2,873,888 shares.
1. Reported share purchases
Rapport Therapeutics director James Healy reported indirect purchases of 969,480 common shares at $21 each. His reported indirect holdings totaled 2,873,888 shares following the purchases.
